GLP-1 medications have surged in popularity across the United States over the past few years, with an estimated one in eight Americans currently using some version of the drugs. Widely hailed by some as miracle treatments, these medications are continuing to undergo scientific research for new potential applications.
However, this rapid national expansion has been accompanied by a growing list of questions and skepticism from various observers. As the drugs reshape American society and health practices, researchers and the public continue to weigh their widespread adoption against emerging uncertainties.
In-depth summary · AI, neutral